Open AccessDosage and Duration of Methylprednisolone Therapy Affect the Occurrence of Cushing Habitus in Patients with Systemic Lupus Erythematosus
Author(s) -
Didi Yudha Permana,
Melisa Intan Barliana,
Laniyati Hamijoyo
Publication year - 2019
Publication title -
journal of pharmacy and bioallied sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.268
H-Index - 36
eISSN - 0976-4879
pISSN - 0975-7406
DOI - 10.4103/jpbs.jpbs_212_19
Subject(s) - medicine , population , diabetes mellitus , outpatient clinic , disease , systemic lupus erythematosus , plasmapheresis , rheumatology , comorbidity , pediatrics , immunology , endocrinology , environmental health , antibody
Systemic lupus erythematosus (SLE) is a multisystem disease with very diverse developments. Corticosteroid is mostly used for the treatment of SLE as antiinflammatory and immunosuppressant, but its long-term use and high dose can cause the side effects such as Cushing habitus.